Last reviewed · How we verify

NCT07097961: PPT Rehab

Paediatric Post-TB Pulmonary Rehab Study

Recruiting now NA Last updated 11 August 2025
What this trial tests

NA trial testing Pulmonary Rehabilitation in Tuberculosis in Children in 40 participants. Currently enrolling.

Timeline
29 July 2025
Primary endpoint
23 February 2026
23 February 2026

Quick facts

Lead sponsorUniversity of Iowa
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment40
Start date29 July 2025
Primary completion23 February 2026
Estimated completion23 February 2026
Sites1 location across Uganda

Drugs / interventions tested

Conditions studied

Sponsor

University of Iowa

Who can join

Adults 6 to 17, any sex, with Tuberculosis in Children or Chronic Lung Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn if a home-based pulmonary rehabilitation program is feasible and acceptable for children ages 6-15 who have recently completed treatment for pulmonary tuberculosis. The main questions it aims to answer are: Can children and caregivers follow a 6-week rehabilitation program? Is the program acceptable and feasible for children and caregivers? Researchers will also explore preliminary changes in walking distance and quality of life. Participants will: Attend a clinic visit for baseline testing, including a 6-minute walk test (6MWT) and the St. George's Respiratory Questionnaire (SGRQ) Receive exercise instructions and a pedometer Complete home-based walking and wall sit exercises twice per week for 6 weeks Receive weekly follow-up from study staff (by phone or home visit) Return to clinic at 6 weeks for follow-up testing

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pulmonary Rehabilitation

Trials testing the same drug.

Other University of Iowa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07097961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing